论文部分内容阅读
目的探讨下呼吸道感染的诊治及临床分析。方法 2011年6月至2012年6月期间,我院诊治的60例下呼吸道感染患者,随机将其分为对照组(头孢唑啉治疗)和观察组(莫西沙星治疗),每组个30例,对两组患者临床疗效、细菌清除率,以及不良反应等情况,进行观察和比较。结果与对照组相比(63.3%),观察组有效率明显升高(85.0%),P<0.05,有统计学意义;与对照组相比(21/28,75.0%),观察组患者细菌清除率明显升高(27/29,93.1%),P<0.05,有统计学意义;治疗期间,两组患者都没有出现严重的不良反应。结论对于下呼吸道感染患者,莫西沙星治疗疗效显著,并且不良反应少,值得临床推广。
Objective To investigate the diagnosis and treatment of lower respiratory tract infection and clinical analysis. Methods Sixty patients with lower respiratory tract infection diagnosed and treated in our hospital from June 2011 to June 2012 were randomly divided into control group (cefazolin treatment) and observation group (moxifloxacin treatment) with 30 Cases, the clinical efficacy of two groups of patients, bacterial clearance, and adverse reactions, etc. were observed and compared. Results Compared with the control group (63.3%), the effective rate in the observation group was significantly higher (85.0%), P <0.05, statistically significant. Compared with the control group (21/28 and 75.0% The clearance rate was significantly higher (27/29, 93.1%), P <0.05, with statistical significance; during the treatment, no serious adverse reactions occurred in both groups. Conclusion For patients with lower respiratory tract infection, moxifloxacin treatment has significant curative effect with less adverse reactions and is worthy of clinical promotion.